The store will not work correctly when cookies are disabled.
3-(3-(Pyridin-3-yl)propyl)-1H-indole
ID: ALA1812653
PubChem CID: 53392060
Max Phase: Preclinical
Molecular Formula: C16H16N2
Molecular Weight: 236.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cncc(CCCc2c[nH]c3ccccc23)c1
Standard InChI: InChI=1S/C16H16N2/c1-2-9-16-15(8-1)14(12-18-16)7-3-5-13-6-4-10-17-11-13/h1-2,4,6,8-12,18H,3,5,7H2
Standard InChI Key: YBFSGMZRHXSPTL-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
0.9027 -5.6916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9016 -6.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6164 -6.9319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6146 -5.2789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3300 -5.6880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3302 -6.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1207 -6.7756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6090 -6.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1203 -5.4310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5262 -4.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3512 -4.7066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7576 -3.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5825 -3.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9970 -4.6946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8212 -4.6878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2284 -3.9693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8054 -3.2561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9825 -3.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 9 2 0
9 5 1 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 1 0
11 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 236.32 | Molecular Weight (Monoisotopic): 236.1313 | AlogP: 3.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.56 | CX LogP: 3.84 | CX LogD: 3.83 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -0.39 |
References
1. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |